ArticleTherapeutic innovation & regulatory science2024
Correction: Advanced Regenerative Medicines for Rare Diseases: A Review of Industry Sponsors Investment Motivations.
Ubaka Ogbogu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.